C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2011
03/22/2011	US7910059 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis
03/22/2011	US7909984 Small volume in vitro analyte sensor
03/22/2011	CA2533079C Imaging fluorescence signals using telecentric optics
03/22/2011	CA2532467C Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization
03/22/2011	CA2510950C Cinnamic acid 4-hydroxylase
03/22/2011	CA2498228C Hcv assay
03/22/2011	CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011	CA2444926C Method for labelling and fragmenting dna
03/22/2011	CA2361590C Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
03/22/2011	CA2354379C Method for isolating dna from biological materials
03/22/2011	CA2335941C Treatment of hyperproliferative disorders
03/22/2011	CA2136958C Method for inhibition of viral morphogenesis
03/18/2011	CA2737048A1 Sonication-assisted metal-enhanced fluorescence (samef)-based bioassays
03/17/2011	WO2011032155A2 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
03/17/2011	WO2011032112A2 Mutant sodium channel nav1.7 and methods related thereto
03/17/2011	WO2011032100A1 Inhibitors of kshv vil6 and human il6
03/17/2011	WO2011032078A1 Detection of x4 strains of hiv-1 by heteroduplex tracking assay
03/17/2011	WO2011032054A2 Analysis of y-chromosome str markers
03/17/2011	WO2011032040A1 Methods of targeted sequencing
03/17/2011	WO2011031999A2 Multi-component nanoparticle structure having detectable magnetic resonance properties
03/17/2011	WO2011031982A1 Methods and compositions for predicting cancer therapy response
03/17/2011	WO2011031895A2 Systems and methods for identifying microparticles
03/17/2011	WO2011031861A1 Methods for predicting responsiveness of a disease or disorder to a receptor tyrosine kinase inhibitor by analysis of mutations in pik3ca
03/17/2011	WO2011031786A2 Compositions and methods for diagnosing autism spectrum disorders
03/17/2011	WO2011031769A2 Methods for risk assessment, treating, and diagnosing myocardial infarction
03/17/2011	WO2011031757A1 Serum markers for identification of cutaneous systemic sclerosis subjects
03/17/2011	WO2011031751A1 Electrochemical test sensor
03/17/2011	WO2011031585A1 Compensation for spectral crosstalk in multiplex nucleic acid amplification
03/17/2011	WO2011031573A1 Methods and kit for protease enzyme assays
03/17/2011	WO2011031471A2 The fungal srebp pathway as a target for anti-fungal agents
03/17/2011	WO2011031438A2 Porcine torque teno virus vaccines and diagnosis
03/17/2011	WO2011031377A1 Optical system for multiple reactions
03/17/2011	WO2011031319A2 Rnai in budding yeast
03/17/2011	WO2011031291A1 Assay for inhibitors of sumo and sumo-targeted ubiquitin ligase pathway
03/17/2011	WO2011031234A1 Method and system for thermal melt analysis
03/17/2011	WO2011030892A1 Novel substrate peptide for rho-kinase
03/17/2011	WO2011030890A1 Method for detection and activity measurement of proteinkinase
03/17/2011	WO2011030838A1 Method for analyzing nucleic acid mutation using array comparative genomic hybridization technique
03/17/2011	WO2011030823A1 Carrier for holding nucleic acids
03/17/2011	WO2011030526A1 Method for detecting microorganism
03/17/2011	WO2011030348A1 A high throughput method for detecting apoptosis of embryonic stages of metazoan helminthic parasites
03/17/2011	WO2011030336A1 Methods of diagnosing amyotrophic lateral sclerosis (als)
03/17/2011	WO2011030334A1 Compositions and methods for treatment, diagnosis and prognosis of mesothelioma
03/17/2011	WO2011030319A1 Peptide nucleic acid probes, kit and method for detecting helicobacter pylori and/or clarithromycin resistance profile and applications
03/17/2011	WO2011030159A1 Method using hla epitope determination
03/17/2011	WO2011030154A1 Detection of quantitative genetic differences
03/17/2011	WO2011030145A1 Nucleic acid amplification employing temperature oscillation
03/17/2011	WO2011030091A1 Assay for candida species
03/17/2011	WO2011029937A1 Ecotoxicological response indicators
03/17/2011	WO2011029899A1 Methods for assessing liver pathologies
03/17/2011	WO2011029835A2 Probes comprising fluorescent artificial nucleobases and use thereof for detection of single base alteration
03/17/2011	WO2011029798A1 Composition and method for imaging stem cells
03/17/2011	WO2011029404A1 Mir-125a for regulating expression of rantes, composition and use thereof
03/17/2011	WO2011029325A1 Improved method for silver-ammonia staining of dna and method for detecting dna
03/17/2011	WO2011011568A8 Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms
03/17/2011	WO2011011366A3 Agents for stimulating activity of methyl modifying enzymes and methods of use thereof
03/17/2011	WO2011001449A3 Pcr primers and methods of detection of salmonella
03/17/2011	WO2010142751A8 In vitro diagnosis/prognosis method and kit for assessment of chronic antibody mediated rejection in kidney transplantation
03/17/2011	WO2010142651A3 Method for determining the risk of developing brain metastasis, and a kit to carry out said method
03/17/2011	WO2010121834A3 Irak kinase family as novel target and biomarker for alzheimer
03/17/2011	WO2010118166A3 Methods of predicting cancer risk using gene expression in premalignant tissue
03/17/2011	WO2010113034A3 Genotyping for risk of atherosclerosis
03/17/2011	WO2010109197A3 Method for sequencing a heteropolymeric target nucleic acid sequence
03/17/2011	WO2010054386A9 Methods, compositions, and devices utilizing microrna to determine physiological conditions
03/17/2011	WO2008020337A3 Methods and kits for evaluating and measuring the oncological status of tissue samples in three-dimentional physiological matrices
03/17/2011	WO2008012696A3 Methods and kits for testing the efficacy of therapeutica compounds and other therapies in a three-dimensional matrix with respect to tumorous cells and tissue
03/17/2011	US20110067147 Development of Very Early Flowering and Normal Fruiting Plum With Fertile Seeds
03/17/2011	US20110067143 Nucleic Acid Molecules and Other Molecules Associated with Transcription in Plants and Uses Thereof for Plant Improvement
03/17/2011	US20110067141 Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof
03/17/2011	US20110067134 Soybean transgenic event mon 87708 and methods of use thereof
03/17/2011	US20110067126 Gab1 involvement in glucose homeostasis regulation by hepatocytes
03/17/2011	US20110067124 Detection and treatment of drug associated angioedema
03/17/2011	US20110067123 Mao-b elevation as an early parkinson's disease biomarker
03/17/2011	US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
03/17/2011	US20110066019 Biosensor Membranes Composed Of Polymers Containing Heterocyclic Nitrogens
03/17/2011	US20110065981 Methods and Compositions for Improved Fertilization and Embryonic Survival
03/17/2011	US20110065908 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/17/2011	US20110065898 Immunosuppressant Target Proteins
03/17/2011	US20110065776 Method for Treating Hepatitis C Infection
03/17/2011	US20110065773 Rna interference mediating small rna molecules
03/17/2011	US20110065758 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions
03/17/2011	US20110065686 Chemical compounds having antiviral activity against dengue virus and other flaviviruses
03/17/2011	US20110065661 Pharmacoperones for correcting disease states involving protein misfolding
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065638 Novel crustacean androgenic gland hormone
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065605 Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
03/17/2011	US20110065604 Element Defined Sequence Complexity Reduction
03/17/2011	US20110065602 Method for detection of gene transcripts in blood and uses thereof
03/17/2011	US20110065600 Sequences associated with tdp-43 proteinopathies and methods of using the same
03/17/2011	US20110065592 Rapid method for identifying polypeptide-nucleic acid interactions
03/17/2011	US20110065171 Methods and devices related to a regulated flow electroporation chamber
03/17/2011	US20110065167 Degradation of Hydrophobic Ester Pesticides and Toxins
03/17/2011	US20110065147 Methods and reagents for modulating cholesterol levels
03/17/2011	US20110065145 Water mamagement
03/17/2011	US20110065144 Method of measuring effects of components on cell reactive oxygen species production
03/17/2011	US20110065143 Multiphoton Scanning Flow Cytometer for Multicellular Aggregates
03/17/2011	US20110065142 Sebocytes, sebocyte-cell line and uses thereof
03/17/2011	US20110065141 Method of Diagnosing Pancreatic Cancer with the Use of N-Binding Type Sugar Chains
03/17/2011	US20110065140 Programmable electromagnetic array for molecule transport

1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 3003